Time: 1:00 PM - 2:15 PM
Location: 400 Ford Hall
New partnerships for developing tuberculosis vaccines and drugs are beginning to run clinical trials primarily in African countries, including South Africa and Senegal. Because these trials are for therapies meant for high TB-burden, low-income countries, they stand in contradistinction to the commercial clinical trials that have been written about by Adriana Petryna and Kaushik Sunder Rajan, among others, who document the various ethical 'variabilities' (Petryna) happening in trials using subjects in low income countries to test therapies intended for high-income markets. Yet the question still needs to be raised of the extent to which these clinical trials - even if they are more ethical - create islands of expertise and health care access that only participants and a small subset of individuals living in the region are able to access. As the anthropologist Cori Hayden has also pointed out, is it enough that no harm is done?
Disability Options: To request disability accommodations, please contact [name, department, e-mail address, phone number].